直接口服抗凝剂（DOACs）：我们是否准备好采用药物遗传学方法？
Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
作者信息
Palmirotta Raffaele
机构信息
Interdisciplinary Department of Medicine, School of Medicine, University of Bari Aldo Moro, 70124 Bari, Italy.
出版信息
J Pers Med. 2021 Dec 29;12(1):17. doi: 10.3390/jpm12010017.
Abstract
Anticoagulants play an important role in reducing complications and mortality associated with thromboembolic disorders, and anticoagulant therapy has been progressively enriched over the last few years with numerous new options [...].
摘要
抗凝剂在降低与血栓栓塞性疾病相关的并发症和死亡率方面发挥着重要作用，并且在过去几年中，抗凝治疗已经通过众多新的选择得到了逐步丰富[……]。
相似文献
1
Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
J Pers Med. 2021 Dec 29;12(1):17. doi: 10.3390/jpm12010017.
2
Effect of Preinjury Oral Anticoagulants on Outcomes Following Traumatic Brain Injury from Falls in Older Adults.
Pharmacotherapy. 2020 Jul;40(7):604-613. doi: 10.1002/phar.2435. Epub 2020 Jul 6.
3
[Direct oral anticoagulant associated bleeding].
J Mal Vasc. 2016 Jul;41(4):272-8. doi: 10.1016/j.jmv.2016.05.008. Epub 2016 Jun 11.
4
High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy.
J Thromb Thrombolysis. 2017 Nov;44(4):435-441. doi: 10.1007/s11239-017-1565-2.
5
Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
J Thromb Thrombolysis. 2020 Jan;49(1):42-53. doi: 10.1007/s11239-019-01923-9.
6
Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
Int J Cardiol. 2018 Nov 1;270:172-179. doi: 10.1016/j.ijcard.2018.06.082. Epub 2018 Jun 19.
7
Direct oral anticoagulants and cardiac surgery: A descriptive study of preoperative management and postoperative outcomes.
J Thorac Cardiovasc Surg. 2021 May;161(5):1864-1874.e2. doi: 10.1016/j.jtcvs.2019.11.119. Epub 2019 Dec 17.
8
Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
Semin Thromb Hemost. 2014 Feb;40(1):121-8. doi: 10.1055/s-0033-1361940. Epub 2013 Dec 31.
9
[Anticoagulation-direct oral anticoagulants].
Internist (Berl). 2017 Jun;58(6):585-597. doi: 10.1007/s00108-017-0243-y.
10
Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the "rubber effect".
PLoS One. 2018 Jun 7;13(6):e0198674. doi: 10.1371/journal.pone.0198674. eCollection 2018.
引用本文的文献
1
Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review.
Front Pharmacol. 2023 Sep 29;14:1244098. doi: 10.3389/fphar.2023.1244098. eCollection 2023.
本文引用的文献
1
Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation.
BMC Health Serv Res. 2021 Oct 2;21(1):1042. doi: 10.1186/s12913-021-07025-8.
2
Pharmacogenetics of Bleeding and Thromboembolic Events in Direct Oral Anticoagulant Users.
Clin Pharmacol Ther. 2021 Sep;110(3):768-776. doi: 10.1002/cpt.2316. Epub 2021 Jun 26.
3
Pharmacogenetics to guide cardiovascular drug therapy.
Nat Rev Cardiol. 2021 Sep;18(9):649-665. doi: 10.1038/s41569-021-00549-w. Epub 2021 May 5.
4
The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects.
Pharmgenomics Pers Med. 2021 Apr 23;14:477-485. doi: 10.2147/PGPM.S291723. eCollection 2021.
5
Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions.
Biomedicines. 2021 Apr 22;9(5):451. doi: 10.3390/biomedicines9050451.
6
Comparative effectiveness of oral anticoagulants in everyday practice.
Heart. 2021 May 26;107(12):962-970. doi: 10.1136/heartjnl-2020-318420.
7
Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review.
J Pers Med. 2021 Jan 11;11(1):37. doi: 10.3390/jpm11010037.
8
Pharmacogenomics of anticoagulation therapy: the last 10 years.
Pharmacogenomics. 2019 Nov;20(16):1113-1117. doi: 10.2217/pgs-2019-0149.
9
Structural insight into substrate and inhibitor discrimination by human P-glycoprotein.
Science. 2019 Feb 15;363(6428):753-756. doi: 10.1126/science.aav7102.
10
Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants.
J Pers Med. 2019 Jan 17;9(1):7. doi: 10.3390/jpm9010007.
Zotero 插件